Medlive Technology Co (HKSE:02192) Additional Paid-In Capital : HK$4,269.7 Mil(As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co Additional Paid-In Capital?

Medlive Technology Co's quarterly additional paid-in capital declined from Dec. 2022 (HK$4,353.4 Mil) to Jun. 2023 (HK$4,264.0 Mil) but then increased from Jun. 2023 (HK$4,264.0 Mil) to Dec. 2023 (HK$4,269.7 Mil).

Medlive Technology Co's annual additional paid-in capital declined from Dec. 2021 (HK$4,773.5 Mil) to Dec. 2022 (HK$4,353.4 Mil) and declined from Dec. 2022 (HK$4,353.4 Mil) to Dec. 2023 (HK$4,269.7 Mil).

Medlive Technology Co Additional Paid-In Capital Historical Data

The historical data trend for Medlive Technology Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co Additional Paid-In Capital Chart

Medlive Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

4,773.46

4,353.40

4,269.74

Medlive Technology Co Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial					4,773.46	-	4,353.40	4,263.99	4,269.74

Medlive Technology Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Medlive Technology Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlive Technology Co (HKSE:02192) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN

Website

https://www.medlive.cn

Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.

Executives

Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
M3, Inc.	2101 Beneficial owner
Sony Group Corporation	2201 Interest of corporation controlled by you
Tian Liping
Zhang Xiaofeng	2101 Beneficial owner
Liu Lingdi	2101 Beneficial owner
Tian Lixin	2101 Beneficial owner
Brown Brothers Harriman & Co.	2502 Approved lending agent
Fidelity Funds	2101 Beneficial owner
Tiantian Co., Limited

Medlive Technology Co (HKSE:02192) Headlines

No Headlines